Cardiovascular Responses to Heat Waves in the Elderly

Sponsor
University of Texas Southwestern Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT04538144
Collaborator
(none)
70
1
67.4
1

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the cardiovascular responses of the elderly to heat wave conditions

Condition or Disease Intervention/Treatment Phase
  • Other: Simulated heat wave

Detailed Description

Heat waves are lethal and cause a disproportionate number of deaths in the elderly relative to any other age group. It is important to note that such deaths are primarily cardiovascular, not hyperthermia itself, in origin. Nevertheless, we know relatively little about the effects of aging on cardiovascular function during actual heat wave-like conditions. The central hypothesis of this work is that the elderly exhibit greater cardiovascular stress during heat wave conditions. Aim 1 will test the hypothesis that recognized impairments in thermoregulatory capacity in the elderly will culminate in heightened cardiovascular stress during prolonged exposure to heat wave conditions. Comprehensive cardiovascular and thermal responses in the elderly, relative to younger adults, will be evaluated during exposure to two prolonged heat wave conditions: hot and humid (replicating the 1995 Chicago heat wave), very hot and dry (replicating the 2018 Los Angeles heat wave). The expected outcome from this body of work will re-shape our understanding of the consequences of aging on cardiovascular function during heat waves

Study Design

Study Type:
Observational
Anticipated Enrollment :
70 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Heat Waves in the Elderly: Reducing Thermal and Cardiovascular Consequences
Actual Study Start Date :
Jan 19, 2021
Anticipated Primary Completion Date :
Aug 31, 2026
Anticipated Study Completion Date :
Aug 31, 2026

Arms and Interventions

Arm Intervention/Treatment
Younger participants

Individuals aged 18-39 years

Other: Simulated heat wave
Individuals will be exposed to thermoneutral climate conditions and two simulated heat wave conditions.

Older participants

Individuals aged 65 years or older

Other: Simulated heat wave
Individuals will be exposed to thermoneutral climate conditions and two simulated heat wave conditions.

Outcome Measures

Primary Outcome Measures

  1. Core body temperature [Prior to and throughout each simulated heat wave exposure; an average of 480 minutes.]

    Core body temperature will be measured from gastrointestinal temperature via an ingestible telemetric pill.

  2. Measures of left ventricular function [Prior to, during, and after each simulated heat wave exposure; approximately 20 min each]

    Measures of left ventricular function, such as ventricular wall motion and ventricular filling, will be obtained from echocardiography images.

Secondary Outcome Measures

  1. Skin temperature [Prior to and throughout each simulated heat wave exposure; an average of 480 minutes.]

    Skin temperature will be measured from small temperature sensitive electrodes attached to the participant's skin

  2. Heart rate [Prior to and throughout each simulated heat wave exposure; an average of 480 minutes.]

    Heart rate will be measured from ECG electrodes attached to the participant

  3. Arterial blood pressure [Prior to and throughout each simulated heat wave exposure; an average of 480 minutes.]

    Arterial blood pressure will be measured using a standard arm blood pressure cuff

  4. Cardiac output [Prior to, during, and after each simulated heat wave exposure; approximately 20 min each]

    Cardiac output (how much blood is ejected from the heart) will be measured using echocardiography and nitrous oxide rebreathing approaches.

  5. Cerebral perfusion [Prior to, during, and after each simulated heat wave exposure; approximately 20 min each]

    Cerebral perfusion will be measured by doppler ultrasound of the internal carotid and vertebral arteries

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy male and female individuals

  • 18-35 years or 65+ years of age

  • Free of any underlying moderate to serious medical conditions

Exclusion Criteria:
  • Known heart disease; other chronic medical conditions requiring regular medical therapy including cancer, diabetes, neurological diseases, uncontrolled hypertension, and uncontrolled hypercholesterolemia.

  • Taking of any medications (such as beta blockers and non-dihydropyridine calcium channel blockers) that have known influences on either cardiac function or sweating responses.

  • Abnormalities detected on routine screening.

  • Individuals who participate in a structured aerobic exercise training program at moderate to high intensities.

  • Current smokers, as well as individuals who regularly smoked within the past 3 years.

  • Body mass index of greater than 30 kg/m^2

  • Pregnant individuals

Contacts and Locations

Locations

Site City State Country Postal Code
1 Texas Health Presbyterian Hospital Dallas Dallas Texas United States 75231

Sponsors and Collaborators

  • University of Texas Southwestern Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Craig Crandall, Professor of Medicine, University of Texas Southwestern Medical Center
ClinicalTrials.gov Identifier:
NCT04538144
Other Study ID Numbers:
  • STU_2019_1759
First Posted:
Sep 3, 2020
Last Update Posted:
Aug 16, 2022
Last Verified:
Aug 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Craig Crandall, Professor of Medicine, University of Texas Southwestern Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 16, 2022